StockMarketWire.com - RBC Capital Markets today downgrades its investment rating on Circassia Pharmaceuticals Plc Ord 0.08p [LON:CIR] to sector performer (from top pick) and cut its price target to 105p (from 430p).

Story provided by StockMarketWire.com